20-09-2022

Clinical trial published

Clinical trial reveals hema.to is faster and better

We're incredibly proud to share that hema.to has been clinically validated in an international, four-center clinical trial! Blood cancer diagnoses weren't just twice as fast, they were made with 8% more sensitivity and 10% more specificity when made with the help of our beautiful, easy-to-use decision-support software. You can download the press release here.

14-07-2022

Medical Valley first prize

hema.to won the first prize ...

... at the Medical Innovation Night in Nürnberg, where we pitched hema.to in front of an audience an an excellent jury consisting of Medical Valley EMN e. V., Siemens Healthineers, aescuvest, GWQ ServicePlus AG, IONOS andFraunhofer IIS. We'll be using our E20k prize money to explore partnerships with GWQ and Siemens Healthineers.

26-05-2022

hema.to receives its CE mark

After months of hard work ...

... we are now compliant with the IVDD. We conform to ISO 13485 (quality management), ISO 14971 (risk management), ISO 62366 (usability), ISO 62304 (software life-cycle management) and IEC 82304 (health software).